"The controlled-release formulation extends our patent protection to 2012 and represents an opportunity to continue to expand our market potential for zileuton by offering a more convenient dosing ...
In the evolving landscape of pharmaceutical development, modified release (MR) tablets have emerged as a cornerstone technology for improving therapeutic outcomes and patient compliance. Unlike ...
https://www.thehindubusinessline.com/news/science/researchers-develop-controlled-release-oral-tablet-for-kala-azar-fungal-infections/article29221280.ece Copy ...
Between April 2005 and December 2005, 216 patients (142 inpatients and 74 outpatients) from ten hospitals were enrolled. There were 126 male and 90 female patients (a ratio of 1.4:1). Of the 216 ...
The median duration of treatment was substantially longer with tapentadol ER (268 days) than with oxycodone CR (59 days), and the incidence of overall gastrointestinal treatment-emergent adverse ...
New Delhi: Researchers at Indian Institute of Technology Hyderabad have developed a method to produce controlled-release oral tablets by loading the drug molecules onto a base that dissolves gradually ...